Dr. Faltas’s study was selected by the SCC Executive Committee as part of the Twelfth Starr Cancer Consortium Grant Competition. The grant will provide $840,000 over two years.
“This generous support from the Starr Cancer Consortium will enable our team to investigate how APOBEC3-mutagenesis shapes the bladder cancer genome especially in critical forms of genomic instability such as chromothripsis. We hope to translate the knowledge we gain from our laboratory experiments into new...